Dichloroacetate Overcomes Oxaliplatin Chemoresistance in Colorectal Cancer through the miR-543/PTEN/Akt/mTOR Pathway

Chemoresistance is responsible for most colorectal cancer (CRC) related deaths. In this study, we found that dichloroacetate (DCA), a pyruvate dehydrogenase kinase (PDK) inhibitor, can be used as a sensitizer for oxaliplatin (L-OHP) chemoresistant CRC cells. The aim of this study was to explore the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cancer
Egile Nagusiak: Liang, Yu, Zhu, Danxi, Zhu, Liming, Hou, Yichao, Hou, Lidan, Huang, Xin, Li, Linjing, Wang, Yu, Li, Lei, Zou, Huimin, Wu, Tianqi, Yao, Mengfei, Wang, Jianhua, Meng, Xiangjun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2019
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6856576/
https://ncbi.nlm.nih.gov/pubmed/31762813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.34650
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak